<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Chromium injection: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Chromium injection: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Chromium injection: Pediatric drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_general" data-topicid="109148" href="/d/html/109148.html" rel="external">see "Chromium injection: Drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list canbnlist drugH1Div drugBrandNames" id="F52872204"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Micro-Cr</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F52531572"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Trace Element, Parenteral</span></li></ul></div>
<div class="block don drugH1Div" id="F57817565"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Adequate intake (AI): Note:</b> Recommended intake from dietary sources (eg, breast milk, formula).</p>
<p style="text-indent:-2em;margin-left:4em;">Neonates: Oral: 0.2 mcg/day (IOM 2001; NIH 2022).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition (PN) additive, maintenance requirement: Note:</b> Chromium contamination is common with other PN products (eg, sodium phosphate, magnesium sulfate), which decreases or eliminates the need for routine supplementation; international guidelines recommend no additional supplementation is necessary (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]; Olson 2019; Srikrishnaraj 2021).</p>
<p style="text-indent:-2em;margin-left:4em;">Preterm and Term Neonates: <b>Note:</b> Doses are expressed as <b>elemental chromium</b>, not chromic chloride.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>ASPEN recommendations (ASPEN 2020):</i></p>
<p style="text-indent:-2em;margin-left:8em;">&lt;3 kg: IV: 0.05 to 0.3 mcg/kg/day.</p>
<p style="text-indent:-2em;margin-left:8em;">≥3 kg: IV: 0.2 mcg/kg/day.</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F46901379"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c6ddc184-6e5a-4727-9f62-02484be5592f">Parenteral nutrition additive, maintenance requirement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Parenteral nutrition (PN) additive, maintenance requirement: Note:</b> Chromium contamination is common with other PN products (eg, sodium phosphate, magnesium sulfate), which decreases or eliminates the need for routine supplementation; international guidelines recommend no additional supplementation is necessary (ASPEN [Corkins 2015]; ASPEN [Mirtallo 2004]; ESPGHAN/ESPEN/ESPR/CSPEN [Domellöf 2018]; Olson 2019; Srikrishnaraj 2021).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents: <b>Note:</b> Doses are expressed as <b>elemental chromium</b>, not chromic chloride.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>ASPEN recommendations (ASPEN 2020):</i></p>
<p style="text-indent:-2em;margin-left:8em;">≤40 kg: IV: 0.2 mcg/kg/day; maximum daily dose: 5 mcg/<b>day</b>.</p>
<p style="text-indent:-2em;margin-left:8em;">&gt;40 kg: IV: 5 to 15 mcg/day.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51108756"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution; chromium is renally eliminated; consider reducing or omitting chromium in patients with severe kidney disease.</p></div>
<div class="block dohp drugH1Div" id="F51108757"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F46901378"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="109148" href="/d/html/109148.html" rel="external">see "Chromium injection: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="44bbdfd6-350f-4c50-a684-347c41f1a848">Chromium, parenteral nutrition supplement</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Chromium, parenteral nutrition supplement:</b>
<b>Note:</b> Chromium contamination is common with other parenteral nutrition products (eg, sodium phosphate, potassium phosphate, and magnesium sulfate), which decrease or eliminate the need for routine supplementation (Olson 2019).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Routine supplement:</b>
<b>IV: </b>No addition of chromium (or a maximum of 1 mcg/day), due to potential accumulation (Vanek 2012).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Deficiency, prevention: Note:</b> For patients with high intestinal fluid loss who are receiving long-term parenteral nutrition (Jeejeebhoy 1977).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>IV:</b> 20 mcg/day added to parenteral nutrition (Jeejeebhoy 1977).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Deficiency, treatment: IV:</b> 150 to 200 mcg/day for up to 2 weeks added to parenteral nutrition, then resume maintenance dose of 20 mcg/day added to parenteral nutrition (Brown 1986; Freund 1979).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50991966"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; use with caution; omit dose in patients with severe kidney disease (Gallieni 1996).</p></div>
<div class="block doha drugH1Div" id="F50989305"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F46914394"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;">There are no adverse reactions listed in the manufacturer's labeling.</p></div>
<div class="block coi drugH1Div" id="F56746798"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Direct IM or IV injection.</p></div>
<div class="block war drugH1Div" id="F46901371"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aluminum toxicity: Contains aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or in patients with renal impairment. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of greater than 4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Use with caution in patients with renal impairment; omit dose in patients with severe kidney disease (Gallieni 1996).</p></div>
<div class="block dosfc drugH1Div" id="F50215969"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:0em;">Strength of chromic chloride injection is expressed as elemental chromium</p></div>
<div class="block foc drugH1Div" id="F50215307"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 40 mcg/10 mL (10 mL)</p></div>
<div class="block geq drugH1Div" id="F50215306"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F50338569"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Chromic Chloride Intravenous)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">40MCG/10ML (per mL): $2.38</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52872205"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, Intravenous: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Micro-Cr: 40 mcg/10 mL (10 mL)</p></div>
<div class="block admp drugH1Div" id="F52614651"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Parenteral: IV: For IV use only. Must be diluted in parenteral nutrition solution prior to administration. Do not administer undiluted by direct injection into a peripheral vein. Solution is acidic; direct IM or IV injection is contraindicated.</p></div>
<div class="block adm drugH1Div" id="F46901384"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">
<b>IV:</b> For IV use only. Must be diluted prior to use in a volume of fluid not less than 100 mL. Do not administer undiluted by direct injection into a peripheral vein. Solution is acidic; direct intramuscular (IM) or intravenous (IV) injection is contraindicated.</p></div>
<div class="block sts drugH1Div" id="F46901374"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Store at 20°C to 25°C (68°F to 77°F).</p></div>
<div class="block usep drugH1Div" id="F53571380"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Chromium supplement for parenteral nutrition (PN) to maintain chromium serum concentrations and to prevent depletion of endogenous stores and subsequent deficiency (FDA approved in pediatric patients [age not specified] and adults).</p></div>
<div class="block cyt drugH1Div" id="F46914474"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F46914471"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block dic drugH1Div" id="F57817996"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dietary adequate intake (IOM 2001): </b></p>
<p style="text-indent:-2em;margin-left:4em;">1 to 6 months: 0.2 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">7 to 12 months: 5.5 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">1 to 3 years: 11 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">4 to 8 years: 15 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">9 to 13 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 25 mcg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 21 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">14 to 18 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 35 mcg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 24 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">19 to 50 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 35 mcg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 25 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">&gt;50 years:</p>
<p style="text-indent:-2em;margin-left:6em;">Males: 30 mcg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">Females: 20 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Pregnancy:</p>
<p style="text-indent:-2em;margin-left:6em;">14 to 18 years: 29 mcg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">19 to 50 years: 30 mcg/day.</p>
<p style="text-indent:-2em;margin-left:4em;">Lactation:</p>
<p style="text-indent:-2em;margin-left:6em;">14 to 18 years: 44 mcg/day.</p>
<p style="text-indent:-2em;margin-left:6em;">19 to 50 years: 45 mcg/day.</p></div>
<div class="block pri drugH1Div" id="F46901369"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Animal reproduction studies have not been conducted.</p></div>
<div class="block pha drugH1Div" id="F46901375"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Helps to maintain normal glucose metabolism and peripheral nerve function and prevents development of impaired glucose tolerance, ataxia, peripheral neuropathy, and a confusional state similar to mild/moderate hepatic encephalopathy.</p></div>
<div class="block phk drugH1Div" id="F46901376"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine and bile.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58213261"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Chrometrace</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-ASPEN.2020">
<a name="ASPEN.2020"></a>American Society for Parenteral and Enteral Nutrition (ASPEN). Appropriate dosing for parenteral nutrition: ASPEN recommendations. http://www.nutritioncare.org/PNDosing. Updated November 17, 2020. Accessed January 10, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3086063">
<a name="3086063"></a>Brown RO, Forloines-Lynn S, Cross RE, Heizer WD. Chromium deficiency after long-term total parenteral nutrition. <i>Dig Dis Sci</i>. 1986;31(6):661-664. doi:10.1007/BF01318699<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/3086063/pubmed" id="3086063" target="_blank">3086063</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Chromic Chloride Injection [package insert]. Lake Forest, IL: Hospira; April 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Corkins.1">
<a name="Corkins.1"></a>Corkins MR, Balint J, Corkins KG, Bobo E, Plogsted S, Yaworski, JA, eds. <i>A.S.P.E.N. Pediatric Nutrition Support Handbook</i>. 2nd ed. American Society for Enteral and Parenteral Nutrition; 2015:chap. 35.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30078716">
<a name="30078716"></a>Domellöf M, Szitanyi P, Simchowitz V, Franz A, Mimouni F; ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Iron and trace minerals. <i>Clin Nutr</i>. 2018;37(6, pt B):2354-2359. doi:10.1016/j.clnu.2018.06.949<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/30078716/pubmed" id="30078716" target="_blank">30078716</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-104057">
<a name="104057"></a>Freund H, Atamian S, Fischer JE. Chromium deficiency during total parenteral nutrition. <i>JAMA</i>. 1979;241(5):496-498.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/104057/pubmed" id="104057" target="_blank">104057</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8672011">
<a name="8672011"></a>Gallieni M, Brancaccio D, Cozzolino M, Sabbioni E. Trace elements in renal failure: are they clinically important? <i>Nephrol Dial Transplant</i>. 1996;11(7):1232-1235. doi:10.1093/ndt/11.7.1232<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/8672011/pubmed" id="8672011" target="_blank">8672011</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Institute of Medicine (IOM) (US) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academies Press; 2001. <a href="https://www.ncbi.nlm.nih.gov/books/NBK222310/" target="_blank">https://www.ncbi.nlm.nih.gov/books/NBK222310/</a>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-192066">
<a name="192066"></a>Jeejeebhoy KN, Chu RC, Marliss EB, Greenberg GR, Bruce-Robertson A. Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition. <i>Am J Clin Nutr</i>. 1977;30(4):531-538. doi:10.1093/ajcn/30.4.531<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/192066/pubmed" id="192066" target="_blank">192066</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15568296">
<a name="15568296"></a>Mirtallo J, Canada T, Johnson D, et al; Task Force for the Revision of Safe Practices for Parenteral Nutrition. Safe practices for parenteral nutrition. <i>JPEN J Parenter Enteral Nutr</i>. 2004;28(6):S39-70.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/15568296/pubmed" id="15568296" target="_blank">15568296</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  National Institutes of Health. Chromium: Fact sheet for health professionals. <a href="https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/" target="_blank">https://ods.od.nih.gov/factsheets/Chromium-HealthProfessional/</a>. Updated June 2, 2022. Accessed January 23, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31197862">
<a name="31197862"></a>Olson LM, Wieruszewski PM, Jannetto PJ, Abbott JC, McMahon MM, Nystrom EM. Quantitative Assessment of Trace-Element Contamination in Parenteral Nutrition Components. <i>JPEN J Parenter Enteral Nutr</i>. 2019;43(8):970-976. doi:10.1002/jpen.1668<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/31197862/pubmed" id="31197862" target="_blank">31197862</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32338772">
<a name="32338772"></a>Srikrishnaraj A, Chambers K, South C, et al. Trace elements' contamination of pediatric parenteral nutrition solutions in Canada: a cause for concern. <i>JPEN J Parenter Enteral Nutr</i>. 2021;45(2):347-356. doi:10.1002/jpen.1836<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/32338772/pubmed" id="32338772" target="_blank">32338772</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22730042">
<a name="22730042"></a>Vanek VW, Borum P, Buchman A, et al; Novel Nutrient Task Force, Parenteral Multi-Vitamin and Multi–Trace Element Working Group; American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Board of Directors. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract</i>. 2012;27(4):440-491. doi:10.1177/0884533612446706<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/chromium-injection-pediatric-drug-information/abstract-text/22730042/pubmed" id="22730042" target="_blank">22730042</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 140646 Version 5.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
